Literature DB >> 9389773

Maspin is an intracellular serpin that partitions into secretory vesicles and is present at the cell surface.

P A Pemberton1, A R Tipton, N Pavloff, J Smith, J R Erickson, Z M Mouchabeck, M C Kiefer.   

Abstract

The tumor suppressor maspin (mammary serpin) was originally identified as a component of human mammary epithelial cells that is downregulated as mammary tumor cells progress from the benign to the invasive and metastatic states. Maspin inhibits cellular invasion, motility, and proliferation, but its mechanism of action is currently unknown. Because the cellular machinery responsible for these processes is cytoplasmic, we have reexamined the tissue distribution and subcellular localization of maspin. We find that maspin, or a maspin-like protein, is present in many human organs, in which it localizes to epithelia. In cultured human mammary myoepithelial cells, maspin is predominantly a soluble cytoplasmic protein that associates with secretory vesicles and is present at the cell surface. In vitro assays show that the vesicle association is due to the existence of an uncleaved facultative secretion signal that allows small amounts of maspin to partition into the endoplasmic reticulum. These results demonstrate that maspin is more widespread than previously believed. The subcellular localization studies indicate that soluble intracellular and vesicle-associated maspin probably play an important role in controlling the invasion, motility, and proliferation of cells expressing it, whereas extracellular maspin may also regulate these processes in adjacent cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9389773     DOI: 10.1177/002215549704501213

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  31 in total

1.  Aberrant methylation of the maspin promoter is an early event in human breast cancer.

Authors:  Bernard W Futscher; Megan M O'Meara; Christina J Kim; Margaret A Rennels; Di Lu; Lynn M Gruman; Richard E B Seftor; Mary J C Hendrix; Frederick E Domann
Journal:  Neoplasia       Date:  2004 Jul-Aug       Impact factor: 5.715

Review 2.  The Opportunity of Precision Medicine for Breast Cancer With Context-Sensitive Tumor Suppressor Maspin.

Authors:  Margarida M Bernardo; Sijana H Dzinic; Maria J Matta; Ivory Dean; Lina Saker; Shijie Sheng
Journal:  J Cell Biochem       Date:  2017-03-21       Impact factor: 4.429

3.  Maspin mediates increased tumor cell apoptosis upon induction of the mitochondrial permeability transition.

Authors:  Khatri Latha; Weiguo Zhang; Nathalie Cella; Heidi Y Shi; Ming Zhang
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

Review 4.  A clinical-pathogenetic approach on associated anomalies and chromosomal defects supports novel candidate critical regions and genes for gastroschisis.

Authors:  Victor M Salinas-Torres; Rafael A Salinas-Torres; Ricardo M Cerda-Flores; Hugo L Gallardo-Blanco; Laura E Martínez-de-Villarreal
Journal:  Pediatr Surg Int       Date:  2018-08-09       Impact factor: 1.827

5.  Maspin, the molecular bridge between the plasminogen activator system and beta1 integrin that facilitates cell adhesion.

Authors:  Michael P Endsley; Yanqiu Hu; Yong Deng; Xiaolin He; Debra J Warejcka; Sally S Twining; Steven L Gonias; Ming Zhang
Journal:  J Biol Chem       Date:  2011-05-23       Impact factor: 5.157

Review 6.  Serpins, immunity and autoimmunity: old molecules, new functions.

Authors:  Mariele Gatto; Luca Iaccarino; Anna Ghirardello; Nicola Bassi; Patrizia Pontisso; Leonardo Punzi; Yehuda Shoenfeld; Andrea Doria
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

7.  Maspin expression in gastrointestinal stromal tumors.

Authors:  Saduman Balaban Adim; Gulaydan Filiz; Ozkan Kanat; Omer Yerci; Halil Ozguc; Berna Aytac
Journal:  World J Surg Oncol       Date:  2010-03-26       Impact factor: 2.754

8.  Clinicopathological significance of maspin expression in breast cancer.

Authors:  Mi Ja Lee; Chae Hong Suh; Zhu-Hu Li
Journal:  J Korean Med Sci       Date:  2006-04       Impact factor: 2.153

9.  Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis.

Authors:  Michael L Cher; Hector R Biliran; Sunita Bhagat; Yonghong Meng; Mingxin Che; Jaron Lockett; Judith Abrams; Rafael Fridman; Michael Zachareas; Shijie Sheng
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-03       Impact factor: 11.205

10.  The role of insulin dependent NO synthesis in the impaired production of maspin in human breast cancer.

Authors:  G V Girish; G Bhattacharya; A Kumar Sinha
Journal:  J Cancer Res Clin Oncol       Date:  2006-02-21       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.